Discover: Parabilis’s Record-Breaking IPO, Preserving Culture Through Growth
8:10 am - Tuesday 8th December 2026
- How can a biotech preserve the culture that built its success while scaling rapidly during its most demanding period of growth to date?
- Learn how Parabilis, celebrating its 10-year anniversary, closed the biggest biotech IPO in history, an oversubscribed round, on the strength of its Helicon technology, which is designed to reach undruggable targets that make up an estimated 80% of cancers
- Discover how Parabilis’s five person HR team is scaling deliberately through this growth, while identifying which parts of its culture must be protected to sustain the momentum
